Controlling leprosy Multidrug treatment is not enough alone
نویسنده
چکیده
I US Committee for Refugees. World refugee survev 1989 in review: Washington, DC: US Committee for Refugees, 1990:30-4. 2 Home Office Statistical Department. Refugee Statistics, UK, Issue 22190. London: HMSO (in press). 3 Karmi G, ed. Refugees and the National Health Service. London: Health and Ethnicity Programme, North West and North East Thames Regional Health Authorities, 1992. 4 Refugee Policy Group. Ensuring the health ofrefugees: taking a broader vision. Washington: Refugee Policy Group, 1990. 5 Dick B. Diseases of refugees-causes, effects, and control. 7rans R Soc Trop Med Hyg 1984;78:734-41. 6 Bonnerjea L. Shaming the world. The needs of women refugees. London: Change and World Universitv Services, 1985. 7 British Refugee Council. Settling for a future: proposals for a British policyv on refugees. London: British Refugee Council, 1987. 8 Holtzman WH, Bornemann TH, eds. Alental health ofimmigrants and refugees. Austin, Texas: Hogg Foundation for Mental Health, University of Texas, 1990. 9 Baker R. ed. The psychosocial problems of refugees. London: British Refugee Council and European Consultation on Refugees and Exiles, 1983:14-21. 10 National Institute of Mlental Health. Mental health services for refugees. Washington, DC: US Department of Health and Human Services, 1991:205-18. 11 Dlick B, Simmonds S. Primary health care with refugees: between the idea and the reality. Trop Doct 1985;15:2-7.
منابع مشابه
Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy.
Treatment for multibacillary leprosy is presently performed with a multidrug therapy (MDT) scheme maintained for 2 years. Leprosy treatment however can benefit from the reduction of length. The lack of interferon-gamma (IFN-gamma) production by lepromatous leprosy (LL) patients' lymphocytes lead us to use this cytokine in the treatment of multibacillary leprosy associated with MDT in the treatm...
متن کاملSteroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).
OBJECTIVE To determine whether addition of low dose prednisolone to multidrug treatment can prevent reaction and nerve function impairment in leprosy. DESIGN Multicentre, double blind, randomised, placebo controlled, parallel group trial. SETTING Six centres in Bangladesh and Nepal. PARTICIPANTS 636 people with newly diagnosed multibacillary leprosy. INTERVENTION Prednisolone 20 mg/day ...
متن کاملA study of relapse in paucibacillary leprosy in a multidrug therapy project, Baroda District, India.
In order to judge the value of therapeutic regimens in paucibacillary leprosy, knowledge of incubation time of relapses is essential, as this will define the length of time patients have to be followed up after treatment has been stopped. The prospective study of relapse includes paucibacillary cases of leprosy belonging to a non-lepromatous group consisting of tuberculoid, neuritic and indeter...
متن کاملReduction in caseload after multidrug therapy in an urban leprosy control programme--a retrospective study in Bombay.
A fall in the active registered case prevalence rate together with a fall in the active caseload per worker after the introduction of multidrug therapy (MDT) is becoming a managerial issue in leprosy control. A retrospective analysis was undertaken to assess the caseload per paramedical worker with reference to active cases for treatment (3341), cases for surveillance (2227) and cases for care ...
متن کاملProgression of leprosy disability after discharge: is multidrug therapy enough?
OBJECTIVE To evaluate the risk factors related to worsening of physical disabilities after treatment discharge among patients with leprosy administered 12 consecutive monthly doses of multidrug therapy (MDT/WHO). METHODS Cohort study was carried out at the Leprosy Laboratory in Rio de Janeiro, Brazil. We evaluated patients with multibacillary leprosy treated (MDT/WHO) between 1997 and 2007. T...
متن کامل